These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 16521657)

  • 1. Short QT syndrome. What is it? Where is it?
    Puri VK; Dwivedi SK; Puri A; Behal K
    Indian Heart J; 2005; 57(6):769-71. PubMed ID: 16521657
    [No Abstract]   [Full Text] [Related]  

  • 2. Short QT syndrome: mechanisms, diagnosis and treatment.
    Bjerregaard P; Gussak I
    Nat Clin Pract Cardiovasc Med; 2005 Feb; 2(2):84-7. PubMed ID: 16265378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short QT syndrome and atrial fibrillation caused by mutation in KCNH2.
    Hong K; Bjerregaard P; Gussak I; Brugada R
    J Cardiovasc Electrophysiol; 2005 Apr; 16(4):394-6. PubMed ID: 15828882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short QT-a silent harbinger of lethal arrhythmias.
    Majumder B; Kumar A
    Indian Heart J; 2008; 60(6):584-7. PubMed ID: 19276501
    [No Abstract]   [Full Text] [Related]  

  • 5. Sudden death associated with short-QT syndrome linked to mutations in HERG.
    Brugada R; Hong K; Dumaine R; Cordeiro J; Gaita F; Borggrefe M; Menendez TM; Brugada J; Pollevick GD; Wolpert C; Burashnikov E; Matsuo K; Wu YS; Guerchicoff A; Bianchi F; Giustetto C; Schimpf R; Brugada P; Antzelevitch C
    Circulation; 2004 Jan; 109(1):30-5. PubMed ID: 14676148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A clinical approach to inherited arrhythmias.
    Cerrone M; Cummings S; Alansari T; Priori SG
    Circ Cardiovasc Genet; 2012 Oct; 5(5):581-90. PubMed ID: 23074337
    [No Abstract]   [Full Text] [Related]  

  • 7. Molecular genetic basis of sudden cardiac death.
    Towbin JA
    Pediatr Clin North Am; 2004 Oct; 51(5):1229-55. PubMed ID: 15331282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Short QT syndrome as an inherited condition].
    Møller DV; Hedley PL; Olesen M; Kanters J; Svendsen JH; Christiansen M
    Ugeskr Laeger; 2011 Feb; 173(6):420-4. PubMed ID: 21299935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short QT syndrome: a very rare arrhythmogenic entity.
    Yontar OC; Yalta K; Yilmaz MB; Turgut OO
    Acta Cardiol; 2008 Oct; 63(5):553-5. PubMed ID: 19013996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo effects of mutant HERG K+ channel inhibition by disopyramide in patients with a short QT-1 syndrome: a pilot study.
    Schimpf R; Veltmann C; Giustetto C; Gaita F; Borggrefe M; Wolpert C
    J Cardiovasc Electrophysiol; 2007 Nov; 18(11):1157-60. PubMed ID: 17711440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short QT syndrome. Update on a recent entity.
    Maury P; Extramiana F; Sbragia P; Giustetto C; Schimpf R; Duparc A; Wolpert C; Denjoy I; Delay M; Borggrefe M; Gaita F
    Arch Cardiovasc Dis; 2008; 101(11-12):779-86. PubMed ID: 19059573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disopyramide is an effective inhibitor of mutant HERG K+ channels involved in variant 1 short QT syndrome.
    McPate MJ; Duncan RS; Witchel HJ; Hancox JC
    J Mol Cell Cardiol; 2006 Sep; 41(3):563-6. PubMed ID: 16842817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac channelopathies associated with infantile fatal ventricular arrhythmias: from the cradle to the bench.
    Kato K; Makiyama T; Wu J; Ding WG; Kimura H; Naiki N; Ohno S; Itoh H; Nakanishi T; Matsuura H; Horie M
    J Cardiovasc Electrophysiol; 2014 Jan; 25(1):66-73. PubMed ID: 24112685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. More on the history of arrhythmia in long QT syndrome.
    Csanády M
    J Am Coll Cardiol; 2004 Sep; 44(6):1339; author reply 1339. PubMed ID: 15364343
    [No Abstract]   [Full Text] [Related]  

  • 15. [Short QT syndrome].
    Wolpert C; Schimpf R; Veltmann C; Borggrefe M
    Herz; 2007 May; 32(3):206-10. PubMed ID: 17497253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arrhythmogenesis in the short-QT syndrome associated with combined HERG channel gating defects: a simulation study.
    Itoh H; Horie M; Ito M; Imoto K
    Circ J; 2006 Apr; 70(4):502-8. PubMed ID: 16565572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-HERG activity and the risk of drug-induced arrhythmias and sudden death.
    De Bruin ML; Pettersson M; Meyboom RH; Hoes AW; Leufkens HG
    Eur Heart J; 2005 Mar; 26(6):590-7. PubMed ID: 15637086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short QT syndrome: clinical findings and diagnostic-therapeutic implications.
    Giustetto C; Di Monte F; Wolpert C; Borggrefe M; Schimpf R; Sbragia P; Leone G; Maury P; Anttonen O; Haissaguerre M; Gaita F
    Eur Heart J; 2006 Oct; 27(20):2440-7. PubMed ID: 16926178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of I(Kr) inactivation by mutation N588K in KCNH2: a link to arrhythmogenesis in short QT syndrome.
    Cordeiro JM; Brugada R; Wu YS; Hong K; Dumaine R
    Cardiovasc Res; 2005 Aug; 67(3):498-509. PubMed ID: 16039272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The year in clinical electrophysiology.
    Scheinman MM; Keung E
    J Am Coll Cardiol; 2005 Mar; 45(5):790-5. PubMed ID: 15734627
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.